<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010084764">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Bonguili, N. C. B.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Fritz, Matthieu</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Lenguiya, L. H.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Mayengue, P. I.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Koukouikila-Koussounda, F.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Dossou-Yovo, L. R.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Badzi, C. N.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Leroy, Eric</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Niama, F. R.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Early circulation of SARS-CoV-2, Congo, 2020</title>
        <secondary-title>Emerging Infectious Diseases</secondary-title>
      </titles>
      <pages>878-880</pages>
      <keywords>
        <keyword>CONGO</keyword>
      </keywords>
      <dates>
        <year>2022</year>
      </dates>
      <call-num>fdi:010084764</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Emerging Infectious Diseases</full-title>
      </periodical>
      <isbn>1080-6040</isbn>
      <accession-num>ISI:000788001700029</accession-num>
      <number>4</number>
      <electronic-resource-num>10.3201/eid2804.212476</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010084764</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2022-06/010084764.pdf</url>
        </pdf-urls>
      </urls>
      <volume>28</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>To determine when severe acute respiratory syndrome coronavirus 2 arrived in Congo, we retrospectively antibody tested 937 blood samples collected during September 2019-February 2020. Seropositivity significantly increased from 1% in December 2019 to 5.3% in February 2020, before the first officially reported case in March 2020, suggesting unexpected early virus circulation.</abstract>
      <custom6>052 ; 050</custom6>
      <custom1>UR224</custom1>
      <custom7>Congo</custom7>
    </record>
  </records>
</xml>
